statistiche ricercatore

Continente	#
NA - Nord America	1.175
AS - Asia	649
EU - Europa	598
SA - Sud America	78
AF - Africa	18
OC - Oceania	4
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.523

Nazione	#
US - Stati Uniti d'America	1.144
SG - Singapore	247
DE - Germania	164
CN - Cina	137
VN - Vietnam	83
HK - Hong Kong	77
IT - Italia	75
SE - Svezia	69
RU - Federazione Russa	58
BR - Brasile	57
IE - Irlanda	57
UA - Ucraina	57
FR - Francia	35
GB - Regno Unito	27
CA - Canada	26
IN - India	22
FI - Finlandia	18
BD - Bangladesh	15
KR - Corea	10
ZA - Sudafrica	10
TR - Turchia	9
AR - Argentina	8
BE - Belgio	7
DK - Danimarca	6
ES - Italia	6
PK - Pakistan	6
IQ - Iraq	5
SA - Arabia Saudita	5
IR - Iran	4
JP - Giappone	4
MY - Malesia	4
PH - Filippine	4
PL - Polonia	4
AL - Albania	3
AT - Austria	3
AU - Australia	3
CO - Colombia	3
EC - Ecuador	3
LT - Lituania	3
MX - Messico	3
NL - Olanda	3
VE - Venezuela	3
JO - Giordania	2
KE - Kenya	2
OM - Oman	2
TH - Thailandia	2
UZ - Uzbekistan	2
YE - Yemen	2
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BH - Bahrain	1
BO - Bolivia	1
CL - Cile	1
DO - Repubblica Dominicana	1
EG - Egitto	1
ET - Etiopia	1
GE - Georgia	1
GR - Grecia	1
ID - Indonesia	1
IL - Israele	1
JM - Giamaica	1
LV - Lettonia	1
MG - Madagascar	1
NG - Nigeria	1
NZ - Nuova Zelanda	1
PE - Perù	1
PY - Paraguay	1
SC - Seychelles	1
SN - Senegal	1
SY - Repubblica araba siriana	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	2.523

Nome	#
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data	511
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data	385
Whole-Exome Sequencing Data - Identifying Somatic Mutations	333
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants	311
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients	290
Molecular mechanisms for the progression of chronic myeloid leukemia	272
Determination of the Activity Profile of Bosutinib, Dasatinib and Nilotinib against 18 Imatinib Resistant Bcr/Abl Mutants	245
BCR and BCR/ABL Regulation during Myeloid Differentiation in Healthy Donors and in Chronic Phase/Blast Crisis CML Patients	241
Totale	2.588

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	18	0	0	0	0	0	0	0	0	0	0	6	12
2021/2022	100	2	6	12	3	8	11	2	6	3	13	8	26
2022/2023	233	35	78	35	19	12	27	1	10	8	3	4	1
2023/2024	169	2	4	9	8	17	50	32	16	14	4	3	10
2024/2025	367	22	41	22	17	24	20	22	15	31	69	34	50
2025/2026	811	106	46	55	94	131	39	151	40	74	75	0	0
Totale													2.588

Bicocca Open Archive